Novavax, Inc. (FRA:NVV1)
Germany · Delayed Price · Currency is EUR 5.81
-0.20 (-3.34%)
Dec 1, 2025, 4:48 PM CET
Novavax Market Cap
Novavax has a market cap or net worth of €935.14 million as of December 2, 2025. Its market cap has decreased by -26.78% in one year.
Market Cap
935.14M
Enterprise Value
494.93M
Revenue
907.40M
Ranking
n/a
PE Ratio
3.21
Stock Price
€5.81
Market Cap Chart
Since July 25, 1996, Novavax's market cap has increased from 27.26M to 935.14M, an increase of 3,330.39%. That is a compound annual growth rate of 12.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 987.98M | -20.58% |
| Dec 31, 2024 | 1.24B | 141.15% |
| Dec 29, 2023 | 515.85M | -37.63% |
| Dec 30, 2022 | 827.03M | -91.31% |
| Dec 31, 2021 | 9.51B | 185.25% |
| Dec 31, 2020 | 3.33B | 3,909.57% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 50.43B |
| Siemens Healthineers AG | 47.80B |
| Bayer Aktiengesellschaft | 29.95B |
| Fresenius SE & Co. KGaA | 26.66B |
| Sartorius Aktiengesellschaft | 15.41B |
| Fresenius Medical Care AG | 11.88B |
| Carl Zeiss Meditec AG | 3.90B |
| Fielmann Group AG | 3.68B |